225 related articles for article (PubMed ID: 10651733)
1. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants.
Rutella S; Rumi C; Laurenti L; Pierelli L; Sora' F; Sica S; Leone G
Br J Haematol; 2000 Jan; 108(1):105-15. PubMed ID: 10651733
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution following transplantation of autologous peripheral CD34+ cells.
Sica S; Laurenti L; Sorà F; Menichella G; Rumi C; Leone G; Rutella S
Acta Haematol; 2001; 105(3):179-87. PubMed ID: 11463993
[TBL] [Abstract][Full Text] [Related]
3. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
[TBL] [Abstract][Full Text] [Related]
4. CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection.
Damiani D; Stocchi R; Masolini P; Michelutti A; Geromin A; Sperotto A; Skert C; Michieli M; Baccarani M; Fanin R
Ann Oncol; 2003 Mar; 14(3):475-80. PubMed ID: 12598356
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Martínez C; Urbano-Ispizua A; Rozman C; Marín P; Rovira M; Sierra J; Montfort N; Carreras E; Montserrat E
Exp Hematol; 1999 Mar; 27(3):561-8. PubMed ID: 10089920
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
8. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.
Stiff PJ; Micallef I; Nademanee AP; Stadtmauer EA; Maziarz RT; Bolwell BJ; Bridger G; Marulkar S; Hsu FJ; DiPersio JF
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1146-53. PubMed ID: 21126595
[TBL] [Abstract][Full Text] [Related]
9. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
10. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study.
Laurenti L; Sica S; Sorà F; Piccirillo N; Ortu La Barbera E; Chiusolo P; Salutari P; Rumi C; Rutella S; Leone G
Haematologica; 1999 Dec; 84(12):1100-3. PubMed ID: 10586212
[TBL] [Abstract][Full Text] [Related]
11. Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation.
Porrata LF; Gastineau DA; Padley D; Bundy K; Markovic SN
Leuk Lymphoma; 2003 Jun; 44(6):997-1000. PubMed ID: 12854901
[TBL] [Abstract][Full Text] [Related]
12. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Diviné M; Boutolleau D; Delfau-Larue MH; Beaujean F; Jouault H; Reyes F; Kuentz M; Bensussan A; Farcet JP; Boumsell L
Br J Haematol; 1999 May; 105(2):349-60. PubMed ID: 10233403
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation.
Eksioglu EA; Kielbasa J; Eisen S; Reddy V
Cytotherapy; 2011 Aug; 13(7):888-96. PubMed ID: 21609205
[TBL] [Abstract][Full Text] [Related]
14. Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell products.
Singh RK; Varney ML; Leutzinger C; Vose JM; Bierman PJ; Buyukberber S; Ino K; Loh K; Nichols C; Inwards D; Rifkin R; Talmadge JE
Int Immunopharmacol; 2007 Aug; 7(8):1033-43. PubMed ID: 17570320
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution after autologous selected peripheral blood progenitor cell transplantation: comparison of two CD34+ cell-selection systems.
Laurenti L; Sorà F; Piccirillo N; Chiusolo P; Cicconi S; Rutella S; Serafini R; Garzia MG; Leone G; Sica S
Transfusion; 2001 Jun; 41(6):783-9. PubMed ID: 11399820
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
Silva MR; Parreira A; Ascensão JL
Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
[TBL] [Abstract][Full Text] [Related]
17. Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age.
Malphettes M; Carcelain G; Saint-Mezard P; Leblond V; Altes HK; Marolleau JP; Debré P; Brouet JC; Fermand JP; Autran B
Blood; 2003 Mar; 101(5):1891-7. PubMed ID: 12406891
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors.
Bomberger C; Singh-Jairam M; Rodey G; Guerriero A; Yeager AM; Fleming WH; Holland HK; Waller EK
Blood; 1998 Apr; 91(7):2588-600. PubMed ID: 9516161
[TBL] [Abstract][Full Text] [Related]
19. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults.
Mackall CL; Stein D; Fleisher TA; Brown MR; Hakim FT; Bare CV; Leitman SF; Read EJ; Carter CS; Wexler LH; Gress RE
Blood; 2000 Jul; 96(2):754-62. PubMed ID: 10887145
[TBL] [Abstract][Full Text] [Related]
20. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
